Antitumor activity of sequential treatment with tyrosine kinase inhibitors (TKI) after failure of RAD001 in metastatic renal cell carcinoma (mRCC) - Grünwald, V; Fenner, M; Seidel, C (J Clin Oncol, 2010)
(suppl; abstr e15132)